Catalyst Crew Technologies Corp. has announced the appointment of Dr. Kevin Rodan Levy as Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer, and Sole Director, effective February 17, 2026. The leadership transition follows the resignation of the company's prior officers and directors, as disclosed in a Form 8-K filed with the U.S. Securities and Exchange Commission.
Dr. Rodan brings extensive experience in healthcare operations, technology-enabled service platforms, and executive management to his new role. Since 2021, he has served as Chief Executive Officer of Grupo Casamed 18 C.A., where he was involved in healthcare delivery management and organizational development initiatives. He has also led EmpleUp, a technology-focused human capital and recruitment platform. His background combines clinical medical training with operational leadership and exposure to emerging technology applications within healthcare systems.
The appointment aligns with Catalyst Crew Technologies' recently announced strategic transition toward artificial intelligence-enabled healthcare technology solutions. The company is focused on developing scalable digital health solutions for emerging markets, with initial emphasis on Latin America. Dr. Rodan's experience positions him to lead this transformation, which includes pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.
"I am honored to lead Catalyst Crew Technologies Corp. at this pivotal stage in its evolution," said Dr. Rodan. "Our focus is on disciplined execution of the Company's strategic transition into AI-enabled healthcare solutions, with particular emphasis on scalable platforms that address access and efficiency challenges in emerging markets. We are committed to building a strong operational foundation and advancing initiatives that position the Company for long-term sustainable development."
The company's strategic direction represents a significant shift toward addressing healthcare challenges in regions with growing demand for modernized healthcare delivery systems. Through technology development initiatives, strategic partnerships, and targeted acquisitions, Catalyst Crew Technologies aims to build an integrated healthcare technology platform. This approach could potentially improve access, efficiency, and care coordination in markets where traditional healthcare infrastructure faces limitations.
For investors and stakeholders following the company's progress, Catalyst Crew Technologies intends to continue providing updates through filings with the U.S. Securities and Exchange Commission and other public disclosures as appropriate. The company maintains an informational website at https://catalystcrewai.com where additional details about its operations and strategy may be found. Official filings can be accessed through the U.S. Securities and Exchange Commission website at https://www.sec.gov.
The leadership change and strategic focus on AI-enabled healthcare solutions come at a time when digital health technologies are gaining traction globally, particularly in emerging markets where infrastructure gaps present both challenges and opportunities. The company's emphasis on scalable platforms suggests a business model that could potentially address systemic healthcare access issues while creating sustainable growth opportunities. However, as a development-stage enterprise, the company has not yet generated revenues from its newly announced business direction, and successful implementation will depend on multiple factors including financing, regulatory compliance, and market acceptance.
